From this month, the cost of a 10-minute, six-monthly Ocrevus (ocrelizumab) subcutaneous injection for relapsing-remitting multiple sclerosis (MS) will be slashed from more than $16,500 to $31.60 for ...

With a new edition of a long-running awareness campaign, Genentech is drawing attention to the talents and passions that are helping people with multiple sclerosis (MS) thrive. | With a new edition of ...

In 2010, at just 20 years old, Chelsea Ashe started losing vision in her left eye and developed severe double vision. Several ...

Tolebrutinib was one of three oral BTK inhibitors that Sanofi acquired as part of its $3.7 billion buyout of Principia ...

Sanofi’s multiple sclerosis hopeful tolebrutinib faced dual setbacks on Monday, with a late-stage failure in one form of the disease and yet another regulatory setback in another.

MS and RA can occur together and share some symptoms. Managing both conditions works best when you coordinate care and treatment with a neurologist and a rheumatologist.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...